ZA919296B - 2beta,19-ethylene bridged steroids as aromatase inhibitors - Google Patents
2beta,19-ethylene bridged steroids as aromatase inhibitorsInfo
- Publication number
- ZA919296B ZA919296B ZA919296A ZA919296A ZA919296B ZA 919296 B ZA919296 B ZA 919296B ZA 919296 A ZA919296 A ZA 919296A ZA 919296 A ZA919296 A ZA 919296A ZA 919296 B ZA919296 B ZA 919296B
- Authority
- ZA
- South Africa
- Prior art keywords
- aromatase inhibitors
- 2beta
- ethylene bridged
- bridged steroids
- steroids
- Prior art date
Links
- 239000003886 aromatase inhibitor Substances 0.000 title abstract 2
- 229940046844 aromatase inhibitors Drugs 0.000 title abstract 2
- 239000005977 Ethylene Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- ORBBRLNBGBWXEF-OQWKOXFXSA-N 3-[(8r,9s,10r,13s,14s)-13-methyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-10-yl]propyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCC[C@@]1([C@H]2CC[C@]3(C)C(=O)CC[C@H]3[C@@H]2CC2)C2=CC(=O)CC1 ORBBRLNBGBWXEF-OQWKOXFXSA-N 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001441 androstanes Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/621,184 US5166201A (en) | 1990-11-30 | 1990-11-30 | 2β,19-ethylene bridged steroids as aromatase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA919296B true ZA919296B (en) | 1992-08-26 |
Family
ID=24489093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA919296A ZA919296B (en) | 1990-11-30 | 1991-11-25 | 2beta,19-ethylene bridged steroids as aromatase inhibitors |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5166201A (xx) |
| EP (1) | EP0488383B1 (xx) |
| JP (1) | JP3143876B2 (xx) |
| KR (1) | KR100190776B1 (xx) |
| CN (1) | CN1033975C (xx) |
| AT (1) | ATE142639T1 (xx) |
| AU (1) | AU635444B2 (xx) |
| CA (1) | CA2056638C (xx) |
| DE (1) | DE69122048T2 (xx) |
| DK (1) | DK0488383T3 (xx) |
| ES (1) | ES2094183T3 (xx) |
| FI (1) | FI102073B1 (xx) |
| GR (1) | GR3021981T3 (xx) |
| HU (1) | HU210830B (xx) |
| IE (1) | IE914168A1 (xx) |
| IL (1) | IL100196A (xx) |
| NO (1) | NO180304C (xx) |
| NZ (1) | NZ240738A (xx) |
| PT (1) | PT99661B (xx) |
| ZA (1) | ZA919296B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19510862A1 (de) * | 1995-03-16 | 1996-09-19 | Schering Ag | Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle |
| ATE473759T1 (de) | 1998-05-22 | 2010-07-15 | Univ Leland Stanford Junior | Bifunktionelle moleküle sowie darauf basierende therapien. |
| EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
| US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
| DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
| CN110075069A (zh) | 2009-05-06 | 2019-08-02 | 实验室护肤股份有限公司 | 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3627756A (en) * | 1970-04-23 | 1971-12-14 | Searle & Co | N-dialkylaminoalkyl-n-(2{62 ,19-epoxy-5{60 -androstan-17{62 -yl)amines/formamides and 3{60 -halo derivatives thereof |
| US4322416A (en) * | 1980-06-27 | 1982-03-30 | Merrell Dow Pharmaceuticals Inc. | 10-Alkynyl steroids |
| GB8501035D0 (en) * | 1985-01-16 | 1985-02-20 | Senior J | Prostaglandins |
| US4882322A (en) * | 1988-10-27 | 1989-11-21 | Merrell Dow Pharmaceuticals Inc. | 3β,17β-hydroxy-substituted steroids and related steroidal compounds |
-
1990
- 1990-11-30 US US07/621,184 patent/US5166201A/en not_active Expired - Fee Related
-
1991
- 1991-11-25 ZA ZA919296A patent/ZA919296B/xx unknown
- 1991-11-25 AU AU88128/91A patent/AU635444B2/en not_active Ceased
- 1991-11-26 NZ NZ240738A patent/NZ240738A/xx unknown
- 1991-11-28 IL IL10019691A patent/IL100196A/en not_active IP Right Cessation
- 1991-11-28 FI FI915623A patent/FI102073B1/fi active IP Right Grant
- 1991-11-29 ES ES91120560T patent/ES2094183T3/es not_active Expired - Lifetime
- 1991-11-29 EP EP91120560A patent/EP0488383B1/en not_active Expired - Lifetime
- 1991-11-29 PT PT99661A patent/PT99661B/pt not_active IP Right Cessation
- 1991-11-29 NO NO914710A patent/NO180304C/no not_active IP Right Cessation
- 1991-11-29 HU HU913739A patent/HU210830B/hu not_active IP Right Cessation
- 1991-11-29 IE IE416891A patent/IE914168A1/en not_active Application Discontinuation
- 1991-11-29 CA CA002056638A patent/CA2056638C/en not_active Expired - Fee Related
- 1991-11-29 DK DK91120560.7T patent/DK0488383T3/da active
- 1991-11-29 AT AT91120560T patent/ATE142639T1/de not_active IP Right Cessation
- 1991-11-29 JP JP03339535A patent/JP3143876B2/ja not_active Expired - Fee Related
- 1991-11-29 DE DE69122048T patent/DE69122048T2/de not_active Expired - Fee Related
- 1991-11-30 KR KR1019910021920A patent/KR100190776B1/ko not_active Expired - Fee Related
- 1991-11-30 CN CN91111251A patent/CN1033975C/zh not_active Expired - Fee Related
-
1996
- 1996-12-11 GR GR960403414T patent/GR3021981T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002676D0 (no) | Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme | |
| IL100196A0 (en) | 2beta,19-ethylene bridged steroids as aromatase inhibitors | |
| DE68911157D1 (de) | Synthese von 6-Methylenandrosta-1,4-dien-3,17-dion-Derivate. | |
| BG103271A (en) | Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means | |
| DK0559706T3 (da) | 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer. | |
| BG103050A (en) | New derivatives of erythromycin, method for their preparation and application as medicamentous forms | |
| UA40574C2 (uk) | Похідні 17,20-епоксипрегнану, спосіб їх одержання, спосіб одержання похідних кортизону і проміжні сполуки | |
| HU9202100D0 (en) | New 16-methyl-pregna-1,4-diene-3,20-dione derivatives | |
| NZ237559A (en) | Halogenoethyl steroid derivatives and pharmaceutical compositions | |
| CA2032311A1 (en) | 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors | |
| ES8604512A1 (es) | Procedimiento para la obtencion de fenilhidrazonpirrolidinas substituidas | |
| JPS52131580A (en) | N-substituted pyridinium-2-sulfonylimines, containing same as active ingredient |